320 related articles for article (PubMed ID: 3487046)
1. Positron emission tomography in Alzheimer's disease.
Duara R; Grady C; Haxby J; Sundaram M; Cutler NR; Heston L; Moore A; Schlageter N; Larson S; Rapoport SI
Neurology; 1986 Jul; 36(7):879-87. PubMed ID: 3487046
[TBL] [Abstract][Full Text] [Related]
2. Cortical abnormalities in Alzheimer's disease.
Foster NL; Chase TN; Mansi L; Brooks R; Fedio P; Patronas NJ; Di Chiro G
Ann Neurol; 1984 Dec; 16(6):649-54. PubMed ID: 6335378
[TBL] [Abstract][Full Text] [Related]
3. Brain metabolism in autism. Resting cerebral glucose utilization rates as measured with positron emission tomography.
Rumsey JM; Duara R; Grady C; Rapoport JL; Margolin RA; Rapoport SI; Cutler NR
Arch Gen Psychiatry; 1985 May; 42(5):448-55. PubMed ID: 3872650
[TBL] [Abstract][Full Text] [Related]
4. Low glucose metabolism during brain stimulation in older Down's syndrome subjects at risk for Alzheimer's disease prior to dementia.
Pietrini P; Dani A; Furey ML; Alexander GE; Freo U; Grady CL; Mentis MJ; Mangot D; Simon EW; Horwitz B; Haxby JV; Schapiro MB
Am J Psychiatry; 1997 Aug; 154(8):1063-9. PubMed ID: 9247390
[TBL] [Abstract][Full Text] [Related]
5. Coronal reconstruction images of glucose metabolism in Alzheimer's disease.
Fukuyama H; Harada K; Yamauchi H; Miyoshi T; Yamaguchi S; Kimura J; Kameyama M; Senda M; Yonekura Y; Konishi J
J Neurol Sci; 1991 Dec; 106(2):128-34. PubMed ID: 1802960
[TBL] [Abstract][Full Text] [Related]
6. Cortical glucose metabolism in psychiatric wandering patients with vascular dementia.
Meguro K; Yamaguchi S; Yamazaki H; Itoh M; Yamaguchi T; Matsui H; Sasaki H
Psychiatry Res; 1996 May; 67(1):71-80. PubMed ID: 8797244
[TBL] [Abstract][Full Text] [Related]
7. Intercorrelations of regional cerebral glucose metabolic rates in Alzheimer's disease.
Horwitz B; Grady CL; Schlageter NL; Duara R; Rapoport SI
Brain Res; 1987 Mar; 407(2):294-306. PubMed ID: 3494486
[TBL] [Abstract][Full Text] [Related]
8. Single photon emission computerised tomography in elderly patients with Alzheimer's disease and multi-infarct dementia. Regional uptake of technetium-labelled HMPAO related to clinical measurements.
McKeith IG; Bartholomew PH; Irvine EM; Cook J; Adams R; Simpson AE
Br J Psychiatry; 1993 Nov; 163():597-603. PubMed ID: 8298827
[TBL] [Abstract][Full Text] [Related]
9. Longitudinal PET Evaluation of Cerebral Metabolic Decline in Dementia: A Potential Outcome Measure in Alzheimer's Disease Treatment Studies.
Alexander GE; Chen K; Pietrini P; Rapoport SI; Reiman EM
Am J Psychiatry; 2002 May; 159(5):738-45. PubMed ID: 11986126
[TBL] [Abstract][Full Text] [Related]
10. Reductions in parietal and temporal cerebral metabolic rates for glucose are not specific for Alzheimer's disease.
Schapiro MB; Pietrini P; Grady CL; Ball MJ; DeCarli C; Kumar A; Kaye JA; Haxby JV
J Neurol Neurosurg Psychiatry; 1993 Aug; 56(8):859-64. PubMed ID: 8350100
[TBL] [Abstract][Full Text] [Related]
11. Positron emission tomography in patients with clinically diagnosed Alzheimer's disease.
McGeer PL; Kamo H; Harrop R; Li DK; Tuokko H; McGeer EG; Adam MJ; Ammann W; Beattie BL; Calne DB
CMAJ; 1986 Mar; 134(6):597-607. PubMed ID: 3512063
[TBL] [Abstract][Full Text] [Related]
12. Impaired cerebral glucose metabolism in prodromal Alzheimer's disease differs by regional intensity normalization.
Küntzelmann A; Guenther T; Haberkorn U; Essig M; Giesel F; Henze R; Schroeter ML; Schröder J; Schönknecht P
Neurosci Lett; 2013 Feb; 534():12-7. PubMed ID: 23182881
[TBL] [Abstract][Full Text] [Related]
13. Association of premorbid intellectual function with cerebral metabolism in Alzheimer's disease: implications for the cognitive reserve hypothesis.
Alexander GE; Furey ML; Grady CL; Pietrini P; Brady DR; Mentis MJ; Schapiro MB
Am J Psychiatry; 1997 Feb; 154(2):165-72. PubMed ID: 9016263
[TBL] [Abstract][Full Text] [Related]
14. Decreased cortical glucose metabolism correlates with hippocampal atrophy in Alzheimer's disease as shown by MRI and PET.
Yamaguchi S; Meguro K; Itoh M; Hayasaka C; Shimada M; Yamazaki H; Yamadori A
J Neurol Neurosurg Psychiatry; 1997 Jun; 62(6):596-600. PubMed ID: 9219745
[TBL] [Abstract][Full Text] [Related]
15. Cerebral metabolic and cognitive studies in dementia with frontal lobe behavioral features.
Kumar A; Schapiro MB; Haxby JV; Grady CL; Friedland RP
J Psychiatr Res; 1990; 24(2):97-109. PubMed ID: 2213642
[TBL] [Abstract][Full Text] [Related]
16. Positron emission tomography in degenerative disorders of the dopaminergic system.
Karbe H; Holthoff V; Huber M; Herholz K; Wienhard K; Wagner R; Heiss WD
J Neural Transm Park Dis Dement Sect; 1992; 4(2):121-30. PubMed ID: 1571076
[TBL] [Abstract][Full Text] [Related]
17. Alzheimer's disease: anterior-posterior and lateral hemispheric alterations in cortical glucose utilization.
Friedland RP; Budinger TF; Koss E; Ober BA
Neurosci Lett; 1985 Feb; 53(3):235-40. PubMed ID: 3872424
[TBL] [Abstract][Full Text] [Related]
18. Cerebral glucose metabolism in patients with frontotemporal dementia.
Ishii K; Sakamoto S; Sasaki M; Kitagaki H; Yamaji S; Hashimoto M; Imamura T; Shimomura T; Hirono N; Mori E
J Nucl Med; 1998 Nov; 39(11):1875-8. PubMed ID: 9829574
[TBL] [Abstract][Full Text] [Related]
19. Differential regional cerebral uptake of (18)F-fluoro-2-deoxy-D-glucose in Alzheimer's disease and frontotemporal dementia at initial diagnosis.
Santens P; De Bleecker J; Goethals P; Strijckmans K; Lemahieu I; Slegers G; Dierckx R; De Reuck J
Eur Neurol; 2001; 45(1):19-27. PubMed ID: 11150836
[TBL] [Abstract][Full Text] [Related]
20. The effect of brain atrophy on cerebral hypometabolism in the visual variant of Alzheimer disease.
Bokde AL; Pietrini P; Ibáñez V; Furey ML; Alexander GE; Graff-Radford NR; Rapoport SI; Schapiro MB; Horwitz B
Arch Neurol; 2001 Mar; 58(3):480-6. PubMed ID: 11255453
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
